ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in ACAD / ACADIA Pharmaceuticals Inc.

On February 14, 2024 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $0 USD as of December 31, 2023. The entity filed a previous 13F-HR on November 15, 2023 disclosing 15,149 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (ACAD) in the form of stock options. The firm currently holds call options representing 17,400 of underlying shares valued at $370,968 USD and put options representing 33,900 of underlying shares valued at $722,748 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ACAD / ACADIA Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -15,149 -100.00 0 -100.00
2023-11-15 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,149 15,149 316 0.0003
2021-08-06 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -26,042 -100.00 0 -100.00
2021-05-14 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 26,042 26,042 670 0.0010
2020-05-11 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -12,265 -100.00 0 -100.00
2020-02-12 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 12,265 12,265 529 0.0013
2019-08-20 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -10,848 -100.00 0 -100.00
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,848 -5,343 -33.00 291 15.02 0.0008
2019-02-13 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 16,191 16,191 253 0.0007
2017-11-15 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -12,711 -100.00 0 -100.00
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 12,711 -29,343 -69.77 365 -74.55 0.0017
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 42,054 -531 -1.25 1,434 2.94 0.0079
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 42,585 42,585 1,393 0.0065
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM Call 17,400 371 n/a n/a n/a
2025-08-18 2025-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ACADIA PHARMACEUTICALS COM Call 29,900 106.21 510 110.74 n/a n/a n/a
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM Call 14,500 -7.64 242 -1.63 n/a n/a n/a
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM Call 15,700 246 n/a n/a n/a
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM Call 19,500 361 n/a n/a n/a
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F ACADIA PHARMACEUTICALS COM Call 18,700 390 n/a n/a n/a
2023-05-15 2023-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ACADIA PHARMACEUTICALS COM Call 24,900 16.36 396 14.78 n/a n/a n/a
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM Call 21,400 345 n/a n/a n/a
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM Call 12,300 209 n/a n/a n/a
2021-08-06 2021-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F ACADIA PHARMACEUTICALS COM Call 49,800 1,280 n/a n/a n/a
2021-02-12 2020-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM Call 30,300 37.73 1,224 15.47 n/a n/a n/a
2020-08-13 2020-06-30 13F ACADIA PHARMACEUTICALS COM Call 22,000 1,060 n/a n/a n/a
2020-05-11 2020-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F ACADIA PHARMACEUTICALS COM Call 50,800 2,193 n/a n/a n/a
2019-08-20 2019-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM Call 37,500 -38.02 1,007 6.34 n/a n/a n/a
2019-02-13 2018-12-31 13F ACADIA PHARMACEUTICALS COM Call 60,500 -20.29 947 -39.91 n/a n/a n/a
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM Call 75,900 1,576 n/a n/a n/a
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F ACADIA PHARMACEUTICALS COM Call 29,500 13.03 1,111 48.33 n/a n/a n/a
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM Call 26,100 -36.19 749 -46.31 n/a n/a n/a
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM Call 40,900 -66.00 1,395 -64.54 n/a n/a n/a
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM Call 120,300 3,934 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM Put 33,900 723 n/a n/a n/a
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM Put 16,400 257 n/a n/a n/a
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM Put 13,800 255 n/a n/a n/a
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F ACADIA PHARMACEUTICALS COM Put 26,300 548 n/a n/a n/a
2021-08-06 2021-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F ACADIA PHARMACEUTICALS COM Put 63,200 1,625 n/a n/a n/a
2021-02-12 2020-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM Put 15,000 80.72 606 51.50 n/a n/a n/a
2020-08-13 2020-06-30 13F ACADIA PHARMACEUTICALS COM Put 8,300 400 n/a n/a n/a
2020-05-11 2020-03-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F ACADIA PHARMACEUTICALS COM Put 39,800 1,718 n/a n/a n/a
2019-08-20 2019-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM Put 32,400 -39.44 870 3.94 n/a n/a n/a
2019-02-13 2018-12-31 13F ACADIA PHARMACEUTICALS COM Put 53,500 15.55 837 -12.90 n/a n/a n/a
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM Put 46,300 961 n/a n/a n/a
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F ACADIA PHARMACEUTICALS COM Put 28,400 -15.48 1,070 11.00 n/a n/a n/a
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM Put 33,600 -42.66 964 -51.75 n/a n/a n/a
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM Put 58,600 -37.99 1,998 -35.34 n/a n/a n/a
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM Put 94,500 3,090 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.